The targeting construct is designed to insert a rox-flanked STOP cassette (RSR) followed by a creERT2 and an FRT-flanked neomycin resistance (neo) cassette into exon 2 of the gene. Expression of CreERT2 driven by the endogenous Gcg gene promoter occurs only after the removal of RSR by Dre recombinase. (J:101977)
Basic Information
(129S6/SvEvTac x C57BL/6NCrl)F1
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count